Table 1: Main international data reporting diabetes as comorbidity risk for COVID-19. 10-13 Table 1: Main international data reporting diabetes as comorbidity risk for COVID-19. 10-13 Table 1: Main international data reporting diabetes as comorbidity risk for COVID-19. 10-13
Country Population Main findings
China
1,590 patients.
A. Mean (SD) age 48.9 (16.3) years. B. 25.1% have≥1 comorbidity. C. Diabetes was second common morbidity (8.2%) after hypertension (16.9%).
Italy
1625 died patients
Analysis of subsample of 355 patients: A. Mean (SD) age 79.5 years (8.1). B. Mean (SD) number of comorbidities 2.7 (1.6). C. 99.2% of patients had ≥1 comorbidity. D. Diabetes was the first common comorbidity (35.5%).
UK
20,133 patients.
A. Median age 73 years (IQR 58, 82). B. 77% had documented comorbidity. C. Diabetes was second common comorbidity (21%) after cardiac disease (31%).
USA
5,700 patients
A. Median age, 63 years (IQR 52-75). B. Median (IQR) Charlson Comorbidity Index score was 4 (2-6) points. C. Diabetes was third common comorbidity (33.8%) after hypertension (56.6%) and obesity (41.7%).